Back in March this year, Boston led the injection of $175M to...

Back in March this year, Boston led the injection of $175M to fund the pivotal study of the Mitral valve by 4C Medical. Judging from that alone I am optimistic about our impending DurAVR trial and potential partnership.
Not advice, DYOR

”Boston Scientific backs mitral valve developer 4C Medical in $175M roundBy Conor HaleMar 7, 2025
Medical’s approach differs from others in the structural heart space, as its globe-shaped AltaValve is designed to fit entirely within the left atrium.

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working on an international pivotal study.The series D proceeds represent a big jump over the company’s previous $35 million raise in early 2022. The latest round was also joined by unnamed new and returning investors.“The enthusiasm for participation in our ATLAS pivotal trial is palpable, and with this strong capital raise and the backing of Boston Scientific, we look forward to clinically demonstrating the safety and effectiveness of the AltaValve System in treating patients with [mitral regurgitation],” 4C Medical CEO Saravana Kumar, Ph.D., said in a statement.”